Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting
September 29, 2022 17:20 ET
|
Reunion Neuroscience Inc.
TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”) today announced the results of the votes held at its September 29, 2022...
Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer
September 28, 2022 07:30 ET
|
Reunion Neuroscience Inc.
TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”), a leader in novel psychedelic drug development committed to innovating...
Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences
September 08, 2022 08:00 ET
|
Reunion Neuroscience Inc.
TORONTO, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, Nasdaq: REUN) ("Reunion"), or (“the Company”), a global leader in the discovery and development of innovative...
Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders
August 31, 2022 07:30 ET
|
Reunion Neuroscience Inc.
TORONTO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, Nasdaq: REUN) ("Reunion"), or (“the Company”), a global leader in the discovery and development of innovative of...
Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022
August 16, 2022 12:46 ET
|
Reunion Neuroscience Inc.
TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd., the "Company" or “Reunion”), a global leader in the discovery and development of innovative of...
Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022
August 15, 2022 17:10 ET
|
Reunion Neuroscience Inc.
Completed corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies.Field Trip Discovery renamed Reunion Neuroscience Inc. (“Reunion” or...
Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing
August 11, 2022 16:28 ET
|
Reunion Neuroscience Inc.; Field Trip Health & Wellness Ltd.
- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and Toronto Stock Exchange under the ticker symbol "FTRP" with such ticker symbol...
Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET
August 08, 2022 08:00 ET
|
Field Trip Health, Ltd.
TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, Nasdaq: FTRP) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange
August 04, 2022 18:29 ET
|
Field Trip Health, Ltd.
– Field Trip Health & Wellness Ltd. to list on the TSX Venture Exchange, with first day of trading expected to occur on or about August 17, 2022. – Field Trip Discovery to be renamed Reunion...
Field Trip Announces First Dosings in Phase I Clinical Study of FT-104
July 21, 2022 07:30 ET
|
Field Trip Health, Ltd.
- First Dosings completed in Australia- Provides Update on Pending Spin-Out and Renaming to Reunion Neurosciences- Announces 5:1 Share Consolidation RatioTORONTO, July 21, 2022 (GLOBE NEWSWIRE) --...